|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2009-9-23
|
|
pubmed:abstractText |
In China, Chloroquine (CQ) and sulfadoxine-pyrimethamine (SP) were abandoned for the treatment of falciparum malaria 20 years ago due to resistance. Subsequent field studies showed a trend of declining CQ and SP resistance in the country. The main purpose of this study was to analyse the molecular markers of antimalarial resistance and thereby to assess the possibility of reintroduction of CQ or SP for falciparum malaria treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1365-3156
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1266-71
|
|
pubmed:meshHeading |
pubmed-meshheading:19772548-Animals,
pubmed-meshheading:19772548-Antimalarials,
pubmed-meshheading:19772548-China,
pubmed-meshheading:19772548-Chloroquine,
pubmed-meshheading:19772548-Drug Resistance, Multiple,
pubmed-meshheading:19772548-Humans,
pubmed-meshheading:19772548-Malaria, Falciparum,
pubmed-meshheading:19772548-Membrane Transport Proteins,
pubmed-meshheading:19772548-Multidrug Resistance-Associated Proteins,
pubmed-meshheading:19772548-Plasmodium falciparum,
pubmed-meshheading:19772548-Point Mutation,
pubmed-meshheading:19772548-Polymerase Chain Reaction,
pubmed-meshheading:19772548-Protozoan Proteins,
pubmed-meshheading:19772548-Sequence Analysis, DNA
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Molecular assessment of Plasmodium falciparum resistance to antimalarial drugs in China.
|
|
pubmed:affiliation |
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, WHO Collaborating Center for Malaria, Schistosomiasis and Filariasis, Shanghai 200025, China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
